As President Donald Trump touts new deals to cut the cost of blockbuster drugs like Wegovy and Zepbound, he’s barely ...
The deal is with drugmakers Eli Lilly and Novo Nordisk to cut prices of their weight-loss drugs and expand Medicare coverage ...
During the open enrollment period, it is extremely important that Medicare beneficiaries review their prescription coverage ...
Medicare enrollees looking for prescription drug coverage for the coming year may need to spend some extra time looking ...
The Trump administration’s pact with drugmakers to lower the price of GLP-1 drugs could pave the way for millions more to ...
MedPage Today on MSN
Medicare to Cover Blockbuster Obesity Drugs
Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for their weight management indications for people with ...
WASHINGTON — The Trump administration is expected to announce the results of the second round of Medicare drug-price negotiations soon.
Trump announces deal with Eli Lilly, Novo Nordisk to lower cost of GLP-1 weight loss drugs Wegovy, Zepbound. Here's what to ...
Medicare coverage will cut obesity-drug prices but open the door to millions of new patients.
Novo Nordisk and Eli Lilly reached deals to lower GLP-1 drug costs for Medicare and Medicaid patients under Trump’s new ...
Consumers will be able to buy discounted brand-name drugs through a government direct sales exchange called Trump Rx, starting in early 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results